Skip to main content
PMC home page
Heart logoLink to Heart
. 1996 Jun;75(6):591–595. doi: 10.1136/hrt.75.6.591

Increased risk of heart valve regurgitation after mediastinal radiation for Hodgkin's disease: an echocardiographic study.

M B Lund 1, H Ihlen 1, B M Voss 1, A F Abrahamsen 1, O Nome 1, J Kongerud 1, M Stugaard 1, K Forfang 1
PMCID: PMC484383  PMID: 8697163

Abstract

OBJECTIVE: To assess by echocardiography the occurrence and degree of late cardiac sequelae after treatment for Hodgkin's disease by radiation and chemotherapy. PATIENTS AND METHODS: In Norway from 1980 to 1988, 129 patients < 50 years old with Hodgkin's disease had curative treatment with mediastinal radiation, with or without chemotherapy. 116 (90%) of these patients (mean (SD) age 37 (7) years, 67 males) were examined by echocardiography 5-13 years after treatment. 40 healthy individuals (mean (SD) age 40 (11), 20 males) were examined as controls. All those examined were in regular sinus rhythm. RESULTS: Grade > 1 (scale 0-3) aortic and/or mitral valvar regurgitation was found in 24% of the patients (15% aortic, 7% mitral, and 2% aortic+mitral), affecting 46% of the females v 16% of the males (P < 0.001). Female gender was a significant risk factor for aortic and mitral regurgitation (odds ratio 4.7, 95% confidence interval 2.0 to 11.2), whereas age, period of follow up, radiation dose, and chemotherapy were not. Thickened pericardium was diagnosed in 15% of the patients. No risk factors were identified. No cases of pericardial thickening or valvar regurgitation grade > 1 were recorded in the control group. Mean values for measured and calculated indices of systolic and diastolic function were within the normal range for patients and controls. The patients had reduced E/A ratio compared with the healthy controls (E/A 1.1 v 2.0, P < 0.001). CONCLUSIONS: Abnormal left sided valvar regurgitation was detected in one fourth of the patients, affecting the aortic valve in more than half of the cases. Females had an increased risk of valvar regurgitation. Echocardiographic screening after high-dose mediastinal radiation is recommended.

Full text

PDF
591

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abrahamsen A. F., Høst H. Mantle field irradiation for stages IA and IIA Hodgkin's disease. Scand J Haematol. 1981 Apr;26(4):306–310. doi: 10.1111/j.1600-0609.1981.tb01666.x. [DOI] [PubMed] [Google Scholar]
  2. Arsenian M. A. Cardiovascular sequelae of therapeutic thoracic radiation. Prog Cardiovasc Dis. 1991 Mar-Apr;33(5):299–311. doi: 10.1016/0033-0620(91)90022-e. [DOI] [PubMed] [Google Scholar]
  3. Bourassa M. G., Wilson J. W., Detre K. M., Kelsey S. F., Robertson T., Passamani E. R. Long-term follow-up of coronary angioplasty: the 1977-1981 National Heart, Lung, and Blood Institute registry. Eur Heart J. 1989 Dec;10 (Suppl G):36–41. doi: 10.1093/eurheartj/10.suppl_g.36. [DOI] [PubMed] [Google Scholar]
  4. Carlson R. G., Mayfield W. R., Normann S., Alexander J. A. Radiation-associated valvular disease. Chest. 1991 Mar;99(3):538–545. doi: 10.1378/chest.99.3.538. [DOI] [PubMed] [Google Scholar]
  5. Glanzmann C., Huguenin P., Lütolf U. M., Maire R., Jenni R., Gumppenberg V. Cardiac lesions after mediastinal irradiation for Hodgkin's disease. Radiother Oncol. 1994 Jan;30(1):43–54. doi: 10.1016/0167-8140(94)90008-6. [DOI] [PubMed] [Google Scholar]
  6. Gottdiener J. S., Katin M. J., Borer J. S., Bacharach S. L., Green M. V. Late cardiac effects of therapeutic mediastinal irradiation. Assessment by echocardiography and radionuclide angiography. N Engl J Med. 1983 Mar 10;308(10):569–572. doi: 10.1056/NEJM198303103081005. [DOI] [PubMed] [Google Scholar]
  7. Gustavsson A., Eskilsson J., Landberg T., Svahn-Tapper G., White T., Wollmer P., Akerman M. Late cardiac effects after mantle radiotherapy in patients with Hodgkin's disease. Ann Oncol. 1990 Sep;1(5):355–363. doi: 10.1093/oxfordjournals.annonc.a057774. [DOI] [PubMed] [Google Scholar]
  8. Hoppe R. T., Coleman C. N., Cox R. S., Rosenberg S. A., Kaplan H. S. The management of stage I--II Hodgkin's disease with irradiation alone or combined modality therapy: the Stanford experience. Blood. 1982 Mar;59(3):455–465. [PubMed] [Google Scholar]
  9. Ihlen H., Amlie J. P., Dale J., Forfang K., Nitter-Hauge S., Otterstad J. E., Simonsen S., Myhre E. Determination of cardiac output by Doppler echocardiography. Br Heart J. 1984 Jan;51(1):54–60. doi: 10.1136/hrt.51.1.54. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Jetne V. Treatment of Hodgkin's disease by radiation therapy. Acta Radiol Suppl. 1972;313:67–75. [PubMed] [Google Scholar]
  11. Jobic Y., Slama M., Tribouilloy C., Lan Cheong Wah L., Choquet D., Boschat J., Penther P., Lesbre J. P. Doppler echocardiographic evaluation of valve regurgitation in healthy volunteers. Br Heart J. 1993 Feb;69(2):109–113. doi: 10.1136/hrt.69.2.109. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Knutsen K. M., Stugaard M., Michelsen S., Otterstad J. E. M-mode echocardiographic findings in apparently healthy, non-athletic Norwegians aged 20-70 years. Influence of age, sex and body surface area. J Intern Med. 1989 Feb;225(2):111–115. doi: 10.1111/j.1365-2796.1989.tb00049.x. [DOI] [PubMed] [Google Scholar]
  13. Kreuser E. D., Völler H., Behles C., Schröder K., Uhrig A., Besserer A., Thiel E. Evaluation of late cardiotoxicity with pulsed Doppler echocardiography in patients treated for Hodgkin's disease. Br J Haematol. 1993 Aug;84(4):615–622. doi: 10.1111/j.1365-2141.1993.tb03136.x. [DOI] [PubMed] [Google Scholar]
  14. Lancaster L. D., Ewy G. A. Cardiac consequences of malignancy and their treatment. Adv Intern Med. 1984;30:275–293. [PubMed] [Google Scholar]
  15. McEniery P. T., Dorosti K., Schiavone W. A., Pedrick T. J., Sheldon W. C. Clinical and angiographic features of coronary artery disease after chest irradiation. Am J Cardiol. 1987 Nov 1;60(13):1020–1024. doi: 10.1016/0002-9149(87)90345-6. [DOI] [PubMed] [Google Scholar]
  16. Minow R. A., Benjamin R. S., Lee E. T., Gottlieb J. A. Adriamycin cardiomyopathy--risk factors. Cancer. 1977 Apr;39(4):1397–1402. doi: 10.1002/1097-0142(197704)39:4<1397::aid-cncr2820390407>3.0.co;2-u. [DOI] [PubMed] [Google Scholar]
  17. Orzan F., Brusca A., Conte M. R., Presbitero P., Figliomeni M. C. Severe coronary artery disease after radiation therapy of the chest and mediastinum: clinical presentation and treatment. Br Heart J. 1993 Jun;69(6):496–500. doi: 10.1136/hrt.69.6.496. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Perrault D. J., Levy M., Herman J. D., Burns R. J., Bar Shlomo B. Z., Druck M. N., Wu W. Q., McLaughlin P. R., Gilbert B. W. Echocardiographic abnormalities following cardiac radiation. J Clin Oncol. 1985 Apr;3(4):546–551. doi: 10.1200/JCO.1985.3.4.546. [DOI] [PubMed] [Google Scholar]
  19. Pohjola-Sintonen S., Tötterman K. J., Salmo M., Siltanen P. Late cardiac effects of mediastinal radiotherapy in patients with Hodgkin's disease. Cancer. 1987 Jul 1;60(1):31–37. doi: 10.1002/1097-0142(19870701)60:1<31::aid-cncr2820600107>3.0.co;2-d. [DOI] [PubMed] [Google Scholar]
  20. Yoshida K., Yoshikawa J., Shakudo M., Akasaka T., Jyo Y., Takao S., Shiratori K., Koizumi K., Okumachi F., Kato H. Color Doppler evaluation of valvular regurgitation in normal subjects. Circulation. 1988 Oct;78(4):840–847. doi: 10.1161/01.cir.78.4.840. [DOI] [PubMed] [Google Scholar]

Articles from Heart are provided here courtesy of BMJ Publishing Group

RESOURCES